Zostavax Information for Healthcare Providers
One of the Recommended Vaccines by Disease
A new shingles vaccine called Shingrix® was licensed by the U.S. Food and Drug Administration (FDA) in 2017. CDC recommends that healthy adults 50 years and older get two doses of Shingrix, 2 to 6 months apart. Shingrix provides strong protection against shingles and PHN. Shingrix is the preferred vaccine, over Zostavax.
- Page last reviewed: January 25, 2018
- Page last updated: January 25, 2018
- Content source: